This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kinoshita, O. Articles by Frank, R. Search for Related Content PubMed PubMed Citation Articles by Kinoshita, O. Articles by Frank, R.

(Circulation. 1995;91:715-721.)
© 1995 American Heart Association, Inc.

Articles

Time- and Frequency-Domain Analyses of the Signal-Averaged ECG in Patients With Arrhythmogenic Right Ventricular Dysplasia

Osamu Kinoshita, MD; Guy Fontaine, MD, PhD; Fernando Rosas, MD; Jorge Elias, MD; Toru Iwa, MD; Joelci Tonet, MD; Gilles Lascault, MD; Robert Frank, MD

From the Center de Stimulation Cardiaque et de Rythmologie, Hopital Jean Rostand, Ivry, France.

Background Arrhythmogenic right ventricular dysplasia (ARVD) is characterized by recurrent ventricular tachycardia of right ventricular origin and a cardiomyopathy with hypokinetic areas involving the free wall of the right ventricle. Subjects have a risk of sudden cardiac death, particularly during sports and strenuous exercise. Routine clinical examinations may be normal, but fragmented or delayed electrograms are usually recorded in the right ventricle of these patients. However, the frequency with which late potentials are detected by conventional time-domain analysis of the signal-averaged ECG (SAECG) is not high. This study evaluated the usefulness of the frequency-domain analysis of the SAECG in addition to the conventional time-domain analysis for a screening test to detect patients with ARVD.

Methods and Results SAECG was recorded by using a bipolar X, Y, and Z lead system in 28 patients with ARVD (mean age, 38±13 years) and 35 age-matched normal subjects (mean age, 35±11 years). The conventional time-domain analysis of the SAECG was performed at two different high-pass filter settings, 25 and 40 Hz, and the low-pass cutoff frequency was fixed at 250 Hz. The fast-Fourier transform analysis of SAECG was performed using a Blackman-Harris window. Area ratio 1 (area of 20 to 50 Hz)/(area of 0 to 20 Hz) and area ratio 2 (area of 40 to 100 Hz)/(area of 0 to 40 Hz) were calculated. In the conventional time-domain analysis, 20 (71%) and 18 (64%) patients had positive criteria at filter settings of 25 and 40 Hz, respectively. In the frequency-domain analysis, 18 (64%) and 20 (71%) patients had abnormal values in area ratios 1 and 2, respectively. Combining the time- and frequency-domain analyses, all patients were judged positive, with a sensitivity of 100% and a specificity of 94%.

Conclusions Each result of the time- and frequency-domain analyses revealed that both methods had equivalent value. Combining the two domain analyses improved the sensitivity without reducing the specificity. These findings suggest that combining the time- and frequency-domain analyses of the SAECG may be useful as a screening test to detect patients with ARVD.

Key Words: tachycardia • cardiomyopathy • Fourier analysis • electrocardiography • potentials

This article has been cited by other articles:

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				A. F. Folino, B. Bauce, G. Frigo, and A. Nava Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings Europace, June 1, 2006; 8(6): 423 - 429. [Abstract] [Full Text] [PDF]

				T. Noda, W. Shimizu, A. Taguchi, T. Aiba, K. Satomi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura Malignant Entity of Idiopathic Ventricular Fibrillation and Polymorphic Ventricular Tachycardia Initiated by Premature Extrasystoles Originating From the Right Ventricular Outflow Tract J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1288 - 1294. [Abstract] [Full Text] [PDF]

				C. Gemayel, A. Pelliccia, and P. D. Thompson Arrhythmogenic right ventricular cardiomyopathy J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1773 - 1781. [Abstract] [Full Text] [PDF]

				D. Le Guludec, H. Gauthier, R. Porcher, R. Frank, D. Daou, S. Benelhadj, A. Leenhardt, T. Lavergne, M. Faraggi, and M. S. Slama Prognostic Value of Radionuclide Angiography in Patients With Right Ventricular Arrhythmias Circulation, April 17, 2001; 103(15): 1972 - 1976. [Abstract] [Full Text] [PDF]

				A Nava, A.F Folino, B Bauce, P Turrini, G.F Buja, L Daliento, and G Thiene Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias Eur. Heart J., January 1, 2000; 21(1): 58 - 65. [Abstract] [PDF]

				K. Matsuo, T. Nishikimi, C. Yutani, T. Kurita, W. Shimizu, A. Taguchi, K. Suyama, N. Aihara, S. Kamakura, K. Kangawa, et al. Diagnostic Value of Plasma Levels of Brain Natriuretic Peptide in Arrhythmogenic Right Ventricular Dysplasia Circulation, December 1, 1998; 98(22): 2433 - 2440. [Abstract] [Full Text] [PDF]

				S. M. Markowitz, B. L. Litvak, E. A. Ramirez de Arellano, J. A. Markisz, K. M. Stein, and B. B. Lerman Adenosine-Sensitive Ventricular Tachycardia : Right Ventricular Abnormalities Delineated by Magnetic Resonance Imaging Circulation, August 19, 1997; 96(4): 1192 - 1200. [Abstract] [Full Text]

				H. A.P. Peeters, A. SippensGroenewegen, B. A. Schoonderwoerd, E. F.D. Wever, C. A. Grimbergen, R. N.W. Hauer, and E. O. Robles de Medina Body-Surface QRST Integral Mapping: Arrhythmogenic Right Ventricular Dysplasia Versus Idiopathic Right Ventricular Tachycardia Circulation, June 17, 1997; 95(12): 2668 - 2676. [Abstract] [Full Text]

				C. Basso, G. Thiene, D. Corrado, A. Angelini, A. Nava, and M. Valente Arrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, Dystrophy, or Myocarditis? Circulation, September 1, 1996; 94(5): 983 - 991. [Abstract] [Full Text]